Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,912 | 6,266 | 8,930 | 11,767 | 15,028 |
| Receivables | N/A | N/A | 3 | 12 | 17 |
| TOTAL | $4,994 | $6,390 | $9,146 | $11,915 | $15,218 |
| Non-Current Assets | |||||
| PPE Net | 73 | 81 | 88 | 96 | 105 |
| Other Non-Current Assets | 11 | 11 | 13 | 21 | 26 |
| TOTAL | $84 | $91 | $101 | $118 | $130 |
| Total Assets | $5,078 | $6,481 | $9,248 | $12,033 | $15,348 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 163 | 276 | 738 | 333 | 636 |
| Accrued Expenses | 103 | 195 | 799 | 1,097 | 585 |
| TOTAL | $266 | $471 | $1,537 | $1,430 | $1,221 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 50 | 36 | 40 | 43 | 46 |
| TOTAL | $50 | $36 | $40 | $43 | $46 |
| Total Liabilities | $315 | $507 | $1,576 | $1,473 | $1,266 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,038 | 14,065 | 14,065 | 14,165 | 14,060 |
| Common Shares | 14 | 14 | 14 | 14 | 14 |
| Retained earnings | -26,543 | -25,256 | -23,495 | -20,463 | -16,716 |
| TOTAL | $4,763 | $5,974 | $7,671 | $10,560 | $14,082 |
| Total Liabilities And Equity | $5,078 | $6,481 | $9,248 | $12,033 | $15,348 |